What were the results of the Harmony Outcomes study?
The Harmony Outcomes study found that albiglutide significantly reduced the risk of major cardiovascular events in patients with type 2 diabetes and cardiovascular disease compared to those given a placebo. The study also showed that albiglutide had a positive effect on glycemic control and body weight. Additionally, albiglutide did not increase the risk of hypoglycemia, heart failure, or death from any cause. These results suggest that albiglutide may be a safe and effective treatment for those with type 2 diabetes and cardiovascular disease.  